Climb Bio (CLYM) Stock
Climb Bio (CLYM) closed at $9.78 on Nov 17, 2026; its Tenet Score is 62 of 100 against 340 Healthcare peers.
35 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $9.78
- Nov 17, 2026
- Market cap
- $583.9M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 1.64 – 18.33
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 62/100
- Solid · 340 Healthcare peers
Industry: Drugs
Climb Bio Inc. scores 62/100. Solid. Strongest on financial health and value, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 62 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
| Kura Oncology IncKURA | 30 | $651.4M |
| Olema Oncology Inc.OLMA | 56 | $644.8M |
| Arbutus Biopharma CorpABUS | 58 | $619.3M |
| Cullinan Therapeutics IncCGEM | 55 | $616.7M |
| Geron Corp.GERN | 55 | $606.8M |
| Wave Life Sciences Inc.WVE | 54 | $566.0M |
| Sana Biotechnology IncSANA | 36 | $563.3M |
| Capricor Therapeutics IncCAPR | 54 | $482.6M |
Common questions
What sector and industry is Climb Bio in?
Climb Bio is in the Healthcare sector and the Drugs industry.
What is Climb Bio's Tenet Score?
Climb Bio's Tenet Score is 62 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




